Answers are grounded in this paper and cite their sources.
Objective: To survey lacrimal surgeons worldwide on their practice of nasolacrimal duct obstruction amid the COVID-19 pandemic. Methods: A 24-question survey was designed to investigate lacrimal surgeons worldwide on their practice of nasolacrimal duct obstruction before the COVID-19 outbreak, during the first wave of COVID-19 pandemic (Spring 2020), and during the study period (12 March 2021 to 12 May 2021). The survey was uploaded to a website, and the link of the survey was sent to international oculoplastic societies for further distribution to their members. Results: A total of 570 respondents from 68 countries or regions were included in the analysis. During the study period, the preferred surgical technique for nasolacrimal duct obstruction was external dacryocystorhinostomy (DCR) [69.9%], followed by endoscopic DCR (46.0%). 95.1% of respondents performed silicone intubation. When the risk of COVID-19 infection was high, respondents preferred external DCR to endoscopic DCR. Respondents used higher levels of PPE for lacrimal irrigation and surgery during the study period than before the COVID-19 outbreak, in compliance with guidelines on aerosol-generating medical procedures. Conclusions: Amid the COVID-19 pandemic, the preferred surgical treatment worldwide for nasolacrimal duct obstruction remains external DCR. The experience gained from the COVID-19 pandemic enables lacrimal surgeons to better prepare for future pandemics.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: